Published in Clin Exp Immunol on October 01, 2002
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res (2007) 0.89
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med (1997) 5.48
A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst (2000) 3.98
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis (2000) 2.00
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
Tissue distribution of the multidrug resistance protein. Am J Pathol (1996) 1.84
Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med (1997) 1.75
Role of CD8 T cells in mycobacterial infections. Immunol Cell Biol (2000) 1.00
A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J Clin Invest (1998) 0.94
The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J Immunol (2000) 0.94
Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res (1994) 0.89
Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet (1992) 2.66
Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology (2009) 2.26
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A (2001) 2.21
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis (2000) 2.00
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol (1999) 1.53
Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. Am J Transplant (2015) 1.47
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol (2001) 1.16
Glomerulopathy associated with parasitic infections. Clin Microbiol Rev (2000) 1.13
Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis (2001) 1.11
Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int (1993) 1.10
Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int (1992) 1.01
Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis (2006) 1.01
CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J Infect Dis (2001) 0.99
Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia. Eur Respir J (2008) 0.98
Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. J Thromb Haemost (2011) 0.97
Sequential measurements of chemokines in urosepsis and experimental endotoxemia. J Clin Immunol (1999) 0.95
ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin. Eur Respir J (2007) 0.94
The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis. Kidney Int (2006) 0.94
Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity. Int Immunol (2001) 0.94
The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. J Thromb Haemost (2005) 0.93
Trichoderma viride infection in a liver transplant recipient. Mycoses (1993) 0.93
Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. Transplant Proc (1990) 0.93
IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol (1994) 0.92
Thrombomodulin in sepsis. Minerva Anestesiol (2012) 0.92
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. Am J Physiol Renal Physiol (2007) 0.88
Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J (2010) 0.88
Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia. J Thromb Haemost (2008) 0.85
Procoagulant protein levels are differentially increased during human endotoxemia. J Thromb Haemost (2003) 0.83
Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J Thromb Haemost (2013) 0.83
Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice. J Med Microbiol (2001) 0.82
Effects of hyperchloremia on blood oxygen binding in healthy calves. J Appl Physiol (1985) (1998) 0.82
Reduced interferon-gamma release in patients recovered from Legionnaires' disease. Thorax (2003) 0.82
Pulsatile perfusion preservation of warm ischaemia-damaged experimental kidney grafts. Br J Surg (2010) 0.81
Role of endogenous interleukin-12 in immune response to staphylococcal enterotoxin B in mice. Infect Immun (2001) 0.81
Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice. Clin Exp Immunol (2004) 0.81
T cell apoptosis in human heart allografts: association with lack of co-stimulation? Am J Pathol (1998) 0.81
Renal expression of CD44 correlates with acute renal allograft rejection. Kidney Int (2006) 0.81
Treatment with everolimus is associated with a procoagulant state. Thromb Res (2013) 0.80
Polyomavirus BK in the pathogenesis of bladder cancer. Neth J Med (2013) 0.78
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody. Clin Exp Immunol (2003) 0.78
CCAAT/enhancer-binding protein delta (C/EBPδ) plays a minor role in renal host defense against uropathogenic Escherichia coli. Transpl Infect Dis (2013) 0.78
Human endotoxemia activates p38 MAP kinase and p42/44 MAP kinase, but not c-Jun N-terminal kinase. Mol Med (2001) 0.78
The importance of testing anti-IL-17 antibodies from different suppliers. Am J Transplant (2011) 0.77
Characteristics of alloreactive T cells measured before renal transplantation. Clin Exp Immunol (2012) 0.77
Ischemia-reperfusion treatment: opportunities point to modulation of the inflammatory response. Kidney Int (2008) 0.77
Hypothermic machine perfusion of kidney grafts: which pressure is preferred? Ann Biomed Eng (2010) 0.76
First clinical experience with polysol solution: pilot study in living kidney transplantation. Transplant Proc (2013) 0.76
A chlorhexidine-releasing epoxy-based coating on titanium implants prevents Staphylococcus aureus experimental biomaterial-associated infection. Eur Cell Mater (2017) 0.75
Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant (2009) 0.75
Fibrosing pericarditis in a patient with encapsulating peritoneal sclerosis. Perit Dial Int (2012) 0.75
Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection? Am J Transplant (2013) 0.75
Early recurrence of hemolytic uremic syndrome in a renal transplant recipient during prophylactic OKT3 therapy. Transplantation (1992) 0.75
Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats. J Thromb Haemost (2012) 0.75
[Nephrotoxicity of anti-CD3 monoclonal antibodies]. Nephrologie (1991) 0.75
T cell subsets in experimental lupus nephritis: modulation by bacterial superantigen. Nephrol Dial Transplant (1999) 0.75
The zebra among horses: extensive abnormalities in a kidney biopsy without clinical signs of kidney disease. Fabry's disease. Neth J Med (2014) 0.75
Effects of systemic administration of rIL-10 in an in vivo model of alloreactivity. Transplantation (1994) 0.75
Interactions between cytochrome P-450 activities and ozone-induced modulatory effects on endothelial permeability in rabbit lungs: influence of gender. Inhal Toxicol (1999) 0.75
Comparison of preservation solutions for washout of kidney grafts: an experimental study. Transplant Proc (2009) 0.75
[Role of interleukin-10 in the regulation of immune responses in infectious diseases]. Rev Med Brux (1994) 0.75
Improved renal function of warm ischemically damaged kidneys using Polysol. Transplant Proc (2009) 0.75